Bio Rad Laboratories Inc
NYSE:BIO

Watchlist Manager
Bio Rad Laboratories Inc Logo
Bio Rad Laboratories Inc
NYSE:BIO
Watchlist
Price: 229.13 USD -1.11%
Market Cap: 6.4B USD

Intrinsic Value

The intrinsic value of one BIO stock under the Base Case scenario is 349.95 USD. Compared to the current market price of 229.13 USD, Bio Rad Laboratories Inc is Undervalued by 35%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BIO Intrinsic Value
349.95 USD
Undervaluation 35%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Bio Rad Laboratories Inc

Valuation History Unavailable

Historical valuation for BIO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare BIO to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BIO?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Bio Rad Laboratories Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bio Rad Laboratories Inc

Current Assets 3B
Cash & Short-Term Investments 1.7B
Receivables 425m
Other Current Assets 951.6m
Non-Current Assets 6.5B
Long-Term Investments 5B
PP&E 682m
Intangibles 711m
Other Non-Current Assets 103m
Efficiency

Free Cash Flow Analysis
Bio Rad Laboratories Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Bio Rad Laboratories Inc

Revenue
2.5B USD
Cost of Revenue
-1.2B USD
Gross Profit
1.4B USD
Operating Expenses
-1.1B USD
Operating Income
308.6m USD
Other Expenses
-2.5B USD
Net Income
-2.2B USD
Fundamental Scores

BIO Profitability Score
Profitability Due Diligence

Bio Rad Laboratories Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Operating Income
Positive Revenue Growth Forecast
39/100
Profitability
Score

Bio Rad Laboratories Inc's profitability score is 39/100. The higher the profitability score, the more profitable the company is.

BIO Solvency Score
Solvency Due Diligence

Bio Rad Laboratories Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
High Altman Z-Score
60/100
Solvency
Score

Bio Rad Laboratories Inc's solvency score is 60/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIO Price Targets Summary
Bio Rad Laboratories Inc

Wall Street analysts forecast BIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIO is 324.19 USD with a low forecast of 262.6 USD and a high forecast of 411.6 USD.

Lowest
Price Target
262.6 USD
15% Upside
Average
Price Target
324.19 USD
41% Upside
Highest
Price Target
411.6 USD
80% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Bio Rad Laboratories Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for BIO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

BIO Insider Trading
Buy and sell transactions by insiders

BIO News

Other Videos
What is the Intrinsic Value of one BIO stock?

The intrinsic value of one BIO stock under the Base Case scenario is 349.95 USD.

Is BIO stock undervalued or overvalued?

Compared to the current market price of 229.13 USD, Bio Rad Laboratories Inc is Undervalued by 35%.

Back to Top